市場調查報告書
商品編碼
1530665
2030 年醫療圖像市場預測:按產品、材料、分銷管道、應用、最終用戶和地區進行的全球分析Medical Imaging Market Forecasts to 2030 - Global Analysis By Product, Material, Distribution Channel, Application, End User and By Geography |
根據Stratistics MRC預測,2024年全球醫療圖像市場規模將達437億美元,預計2030年將達到709億美元,預測期內複合年成長率為8.4%。
醫學影像是一種用於創建身體內部視覺表示以進行臨床分析和醫療干預的技術和過程。這些技術包括各種模式,例如 X 光、超音波、電腦斷層掃描 (CT)、磁振造影(MRI) 和核子醫學影像。每種模式利用不同的原理來捕捉器官、組織和結構的詳細影像,以幫助診斷、監測和製定各種醫療狀況的治療計劃,確保準確有效的醫療照護。
根據聯合國預測,2021年新生兒的平均壽命預計為71歲,比1950年出生的人長近25歲,女性普遍比男性多活5年。
提高人們對早期檢測好處的認知
人工智慧診斷和高解析度顯像模式等技術進步正在增強早期檢測能力,從而提高人們對早期疾病檢測益處的認知,並推動市場成長。這有助於及時介入、改善患者治療效果並降低醫療成本。全球各國政府和醫療保健提供者越來越重視早期檢測舉措,刺激了對創新醫療圖像技術的需求。
輻射暴露
低劑量電腦斷層掃描、劑量監測系統和鉛屏蔽的進步等技術可降低風險。診斷功效和輻射安全之間的平衡仍然至關重要,並影響設備的進步和操作通訊協定。持續的技術創新旨在在不影響診斷品質的情況下減少輻射計量,促進跨模式更安全的環境,並改善患者照護和醫護人員的安全。這是抑制市場成長的主要因素。
慢性病負擔增加
心血管疾病、癌症和神經系統疾病等疾病推動了對 MRI、 電腦斷層掃描和超音波等先進影像技術的需求。這些技術能夠實現慢性病的早期診斷、治療計劃和監測,有助於擴大市場成長。此外,已開發地區的人口老化和新興經濟體不斷擴大的醫療基礎設施進一步推動了對醫療圖像解決方案的需求。
缺乏合格的人才
缺乏合格的人才是這個市場的一個主要問題。這種短缺影響了影像處理設施的有效運作並延誤了患者的治療。對熟練放射科醫生、技術人員和支援人員的需求超過了可用勞動力,特別是在專業領域。解決此問題需要加強培訓計畫、招募工作和留任策略,以確保充足的人員配備水準並維持高標準的診斷影像服務。
COVID-19 的爆發對市場產生了重大影響,最初擾亂了供應鏈和選擇性程序。然而,遠端醫療和基於人工智慧的診斷的引入也在加速。製造商專注於加強消毒通訊協定和開發更安全的成像技術。由於醫療保健挑戰持續存在,需要更快的診斷和改善患者的治療結果,疫情後的恢復看到了對先進成像方式的新投資。
預計在預測期內,乳房X光攝影系統產業將成為最大的產業
預計乳房X光攝影系統將成為預測期內最大的市場。乳房X光攝影系統市場包括用於乳癌篩檢和診斷的設備,包括數位和類比系統。主要促進因素包括乳癌發病率上升以及提高影像品質和患者舒適度的技術進步。市場成長是由意識增強、政府措施和醫療基礎設施改善所推動的。
神經病學領域預計在預測期內複合年成長率最高
由於提高影像解析度和效率的技術進步,預計神經學領域在預測期內將出現最高的複合年成長率。功能性 MRI 等先進成像技術可追蹤任務期間的大腦活動,有助於規劃神經外科手術和研究認知功能。新興技術包括用於繪製神經連接圖的擴散張量成像 (DTI) 和用於檢測神經病學生化變化的分子成像。
預計北美在預測期內將佔據最大的市場佔有率。在慢性病增加、人口老化和醫療保健支出等因素的推動下,該地區在市場規模和創新方面處於世界領先地位。人工智慧和機器學習的不斷進步也推動了市場的發展,這些技術正在提高診斷的準確性和效率。法律規範確保病患安全和資料隱私的高標準,從而增強醫療保健提供者和病患之間的信任和信心。
由於醫療保健成本上升、技術進步和診斷程序需求不斷增加,預計亞太地區在預測期內將保持最高的複合年成長率。中國、日本、印度和韓國等國家透過擴大醫療基礎設施和採用 MRI、CT、超音波和 X 光等診斷影像方式做出了重大貢獻。該市場也受到旨在改善全部區域醫療保健的可近性和品質的政府舉措的影響。
According to Stratistics MRC, the Global Medical Imaging Market is accounted for $43.7 billion in 2024 and is expected to reach $70.9 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Medical imaging is technique and process used to create visual representations of the interior of a body for clinical analysis and medical intervention. These techniques include various modalities such as X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine imaging. Each modality utilizes different principles to capture detailed images of organs, tissues, and structures, aiding in the diagnosis, monitoring, and treatment planning of various medical conditions, ensuring precise and effective medical care.
According to the United Nations, a newborn in 2021 is projected to have an average lifespan of nearly 25 years longer than someone born in 1950, achieving an average age of 71 years, with females typically living five years longer than males.
Increasing awareness of the benefits of early disease detection
Increasing awareness of the benefits of early disease detection is driving growth in the market, due to advancement in technology, such as AI-powered diagnostics and high-resolution imaging modalities, enhance early detection capabilities. This fosters timely intervention, improving patient outcomes and reducing healthcare costs. Governments and healthcare providers globally are increasingly prioritizing early detection initiatives, fueling demand for innovative medical imaging technologies.
Radiation exposure
Technologies like low-dose CT scans, dose monitoring systems, and lead shielding advancements mitigate risks. Balancing diagnostic efficacy with radiation safety remains pivotal, influencing equipment advancements and operational protocols. Continuous innovation targets reducing exposure without compromising diagnostic quality, promoting safer environments across modalities, enhancing patient care and healthcare provider safety. This is the major factor impeding the growth of the market.
Rising burden of chronic diseases
Conditions like cardiovascular diseases, cancer, and neurological disorders drive demand for advanced imaging technologies such as MRI, CT scans, and ultrasound. These technologies enable early diagnosis, treatment planning, and monitoring of chronic conditions, contributing to increased market growth. Additionally, aging populations in developed regions and the expanding healthcare infrastructure in emerging economies further propel the demand for medical imaging solutions.
Shortage of qualified personnel
In the market, a significant challenge is the shortage of qualified personnel. This shortage impacts the efficient operation of imaging facilities and delays patient care. The demand for skilled radiologists, technicians, and support staff exceeds the available workforce, especially in specialized fields. Addressing this issue requires enhanced training programs, recruitment initiatives, and retention strategies to ensure adequate staffing levels and maintain high standards of diagnostic imaging services.
The COVID-19 pandemic significantly impacted the market, initially causing disruptions in supply chains and elective procedures. However, it also accelerated the adoption of telemedicine and AI-driven diagnostics. Manufacturers focused on enhancing sanitization protocols and developing safer imaging technologies. Post-pandemic recovery witnessed renewed investments in advanced imaging modalities, driven by the need for faster diagnostics and improved patient outcomes amidst ongoing healthcare challenges.
The mammography systems segment is expected to be the largest during the forecast period
The mammography systems is expected to be the largest during the forecast period. The mammography systems in market encompass devices used for breast cancer screening and diagnosis, including digital and analog systems. Key drivers include rising breast cancer incidence and technological advancements enhancing imaging quality and patient comfort. Market growth is propelled by increased awareness, government initiatives, and healthcare infrastructure development.
The neurology segment is expected to have the highest CAGR during the forecast period
The neurology segment is expected to have the highest CAGR during the forecast period owing to technological advancements enhancing imaging resolution and efficiency. Advanced imaging techniques like functional MRI track brain activity during tasks, aiding in neurosurgical planning and studying cognitive functions. Emerging technologies include diffusion tensor imaging (DTI) for mapping neural connections and molecular imaging for detecting biochemical changes in neurology.
North America is projected to hold the largest market share during the forecast period. The region leads globally in terms of market size and innovation, driven by factors such as increasing chronic diseases, aging population, and healthcare expenditure. The market is also buoyed by ongoing advancements in AI and machine learning, enhancing diagnostic accuracy and efficiency. Regulatory frameworks ensure high standards of patient safety and data privacy, fostering trust and reliability among healthcare providers and patients alike.
Asia Pacific is projected to hold the highest CAGR over the forecast period driven by increasing healthcare expenditure, technological advancements, and rising demand for diagnostic procedures. Countries like China, Japan, India, and South Korea are significant contributors due to their expanding healthcare infrastructure and adoption of diagnostic imaging modalities such as MRI, CT, ultrasound, and X-ray. The market is also influenced by government initiatives aimed at improving healthcare accessibility and quality across the region.
Key players in the market
Some of the key players in Medical Imaging market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Hitachi Medical Systems, Hologic, Inc., Carestream Health, Fujifilm Medical Systems, Samsung Medison, Esaote S.p.A., Konica Minolta Healthcare, Mindray Medical International Limited, Medtronic, Stryker Corporation, Neusoft Medical Systems, Allengers Medical Systems Limited and United Imaging Healthcare.
In January 2024, Canon Medical Systems Corporation along with Olympus Corporation declared their partnership to work together on Endoscopic Ultrasound Systems. Under this agreement, Canon Medical is tasked with the development and manufacturing of diagnostic ultrasound systems for use in Endoscopic Ultrasonography, while Olympus will handle the sales and marketing activities.
In February 2023, GE Healthcare announced that it reached an agreement to acquire a privately held AI healthcare provider, Caption Health, Inc. Caption Health develops clinical applications to help with early disease diagnosis and uses AI to help with ultrasound scans.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.